| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,911 |
4,703 |
$162K |
| 20611 |
|
9,040 |
4,431 |
$125K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,998 |
3,983 |
$83K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
2,431 |
1,280 |
$68K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
872 |
405 |
$40K |
| 76881 |
|
1,756 |
1,648 |
$26K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
367 |
366 |
$18K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
3,832 |
3,176 |
$18K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
1,288 |
550 |
$16K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
1,347 |
569 |
$8K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
264 |
119 |
$6K |
| 62323 |
|
91 |
88 |
$4K |
| 76942 |
|
251 |
225 |
$4K |
| 64483 |
|
85 |
80 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
53 |
53 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
194 |
184 |
$901.94 |
| 64484 |
|
46 |
44 |
$548.07 |
| 20550 |
|
13 |
12 |
$175.30 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$21.68 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
196 |
186 |
$0.00 |